IPP Bureau
Zydus Lifesciences acquires rights to market MonoFerric injections in India and Nepal
By IPP Bureau - September 10, 2022
MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
Lynparza with Bevacizumab demonstrates survival in certain patients with first-line advanced ovarian cancer
By IPP Bureau - September 10, 2022
The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
Vandemark gets investment from SK Capital with Comvest partners
By IPP Bureau - September 09, 2022
SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
Dr. Reddy's Laboratories launches Lenalidomide Capsules in the U.S.
By IPP Bureau - September 09, 2022
Celgene agreed to provide Dr. Reddy's with a license to sell volume-limited amounts of generic lenalidomide capsules in the U.S.
Allurion launches weight management solution in India
By IPP Bureau - September 09, 2022
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Panacea Biotec received US FDA communication for Baddi facility
By IPP Bureau - September 09, 2022
The OAI classification implies that the USFDA expects further corrective actions and may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved
We can create Seva Bhav by donating organs...: Dr. Mandaviya
By IPP Bureau - September 09, 2022
Despite having rich knowledge and defined responsibility, there has been less than expected response towards organ donation from our citizens
World BioProtection Forum India & Sharda University to host World BioProtection Summit – India 2022
By IPP Bureau - September 09, 2022
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
Evonik appoints Dr. Gaetano Blanda as Head of Animal Nutrition Business Line
By IPP Bureau - September 08, 2022
Blanda will be responsible for overseeing Evonik’s amino acids and functional feed additives business and the expansion of its precision livestock farming approach
Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally
By IPP Bureau - September 08, 2022
Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
Health Secretary addresses workshop on 'Roadmap to Strengthen Public Health Preparedness and Response Capabilities of Points of Entry (PoEs) in India'
By IPP Bureau - September 08, 2022
India is an example in front of the world to contribute towards strengthening Points of Entry during a public health emergency
President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9
By IPP Bureau - September 08, 2022
The virtual event will be attended by representatives from state & district health administration, corporates, industries, civil society, and NGOs as the country reiterates its commitment towards TB elimination by 2025
Healthcare sector is expected to reach US $50 bn by 2025
By IPP Bureau - September 08, 2022
Healthcare has become more focused on innovation and technology over the past two years and 80% of healthcare systems are aiming to increase their investment in digital healthcare tools in the coming five years
Cipla receives US FDA approval for Revlimid (Lenalidomide) capsules
By IPP Bureau - September 08, 2022
Depending on the type of cancer, it can be used as monotherapy or combination as a part of first line regimen, maintenance regimen or relapsed settings
SIRIO appoints Lonza’s Sara Lesina as General Manager in Europe
By IPP Bureau - September 08, 2022
Her appointment further strengthens the CDMO’s strategy to become the nutraceutical R&D hub for brands looking for agile partners with large scientific and development resources
